id
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2023-12-26 11:27:33
expired found date
-
created at
2024-06-10 15:11:20
updated at
2026-01-07 09:17:52
length
16
crc
49305
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
816952
mp size raw text
10121
mp inner links count
1
mp inner links status
20 (imported)
title
IPD Analytics | The Industry Leader in Drug Life-Cycle Insights
description
IPD Analytics offers industry leading life-cycle analysis, clinical and formulary insights, brand and generic market impact forecasts, and coding and reimbursement information
site name
IPD Analytics
author
updated
2025-12-22 23:27:26
raw text
IPD Analytics | The Industry Leader in Drug Life-Cycle Insights top of page Subscriber login: SUBMIT Remember me Home About IPD Our Solutions US Life-Cycle Insights Global Life-Cycle Insights - Europe - Japan - Canada - Australia - Brazil - Mexico - India - Korea - Russia - China - Taiwan Global Patent Search (GPS) Legislation & Government Insights Data STACK Payer & Provider Insights Access Hub Market & Financial Insights Rebate Monitor Primary Market Insights Coding & Reimbursement Budget Impact Med-Tech Insights Our Subscribers Brand Manufacturers Generic Manufacturers Payers and Managed Care Hospitals and Health Systems Supply Chain Members Institutional Investors Other Industry Stakeholders Podcast The Race for the First NASH Approval Advanced Strategies for Cost Containment Eylea 360 Insights Limited Distribution Drugs Part 1 & 2 Patient Financial Assistance Programs Growing Class of Compl...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
7695
text words
1165
text unique words
409
text lines
394
text sentences
16
text paragraphs
2
text words per sentence
72
text matched phrases
3
text matched dictionaries
4
links self subdomains
0
links other subdomains
links other domains
1 - ipdcapital.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
2 - linkedin.com, twitter.com
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-22 23:27:26
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
30 (processing completed, results pushed to table crawler_sitemaps.ext_domain_sitemap_lists)
sitemap review version
1
sitemap urls count
169
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-01-12 13:53:16
sitemap process date
2024-11-18 02:32:04
sitemap first import date
-
sitemap last import date
-